Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Abstract

Get full access to this article

View all access options for this article.

References

Piel

Steinberg

Rees

DC.

Sickle cell disease. N Engl J Med. 2017;376:1561-1573. doi:10.1056/NEJMra1510865

Han

Saraf

Kavoliunaite

, et al. Program expansion of a day hospital dedicated to manage sickle cell pain. Am J Hematol. 2018;93:E20-E21. doi:10.1002/ajh.24938

Tanabe

Silva

Bosworth

, et al. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD). Am J Hematol. 2018;93:159-168. doi:10.1002/ajh.24948

Schefft

Swaffar

Newlin

, et al. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department. Pediatr Blood Cancer. 2018;65: e27274. doi:10.1002/pbc.27274